Related Experiment Videos
Prostaglandins and antiprogestins
1Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement
|January 1, 1989
Summary
Mifepristone combined with prostaglandin analogs offers an effective non-surgical early pregnancy termination, significantly reducing side effects like uterine pain compared to prostaglandins alone.
Area of Science:
- Reproductive Medicine
- Pharmacology
Background:
- Non-surgical early pregnancy termination is of significant interest.
- Prostaglandin analogs are used but cause severe gastrointestinal side effects and uterine pain.
Purpose of the Study:
- To evaluate the efficacy and safety of mifepristone in combination with prostaglandin analogs for early pregnancy termination.
Main Methods:
- Mifepristone (50 mg/day) followed by low-dose sulprostone injection (0.25 mg).
- Combination of mifepristone with vaginal gemeprost (0.5-1.0 mg).
Main Results:
- Mifepristone and sulprostone combination achieved 94% complete abortion rates.
- This combination resulted in rare gastrointestinal side effects and less uterine pain.
- Mifepristone with vaginal gemeprost showed comparable effectiveness.
Conclusions:
- Mifepristone significantly enhances the efficacy of prostaglandin analogs for early pregnancy termination.
- The combination therapy offers a safer and more tolerable alternative to prostaglandin analogs alone.
- Oral prostaglandin analogs may be a future option for this treatment regimen.